Most Recent Articles from Pharma Marketletter

• European drug regulators revisit SSRIs, warn doctors on antidepressants 

  The issue of the safety of selective serotonin reuptake inhibitor antidepressants was the subject of an extraordinary meeting of the European...

  12/20/04 · More from publication

• France: reimbursement cut on vasodilators 

  A regulation issued by the French government has cut reimbursement rates on 29 vasodilator drugs from 65% to 35% on the grounds that the medical...

  12/20/04 · More from publication

• Future of parallel drug trade in enlarged Europe. 

  When 10 new countries joined the European Union in May, many observers expected to see an abrupt rise in the volume of parallel trade in...

  12/20/04 · More from publication

• Germany: statutory health care reform a major election issue - by Gilbert Mertens*. 

  Germans are struck by the observation that Germany is a stagnant society. For years, they have seen their social-consensus model as the blueprint...

  12/20/04 · More from publication

• Mylan/King merger: the saga continues 

  The latest development in what is becoming an increasingly complicated merger between the USA-based firms Mylan and King Pharmaceuticals may...

  12/20/04 · More from publication

• UK NICE should have role in pharma R&D target-setting, parliament is told 

  Pressures from industry, doctors and patient groups mean that drugs are sometimes introduced into routine clinical practice in the UK National...

  12/06/04 · More from publication

View more »